Xtant Historical Balance Sheet
XTNT Stock | USD 0.40 0.01 2.44% |
Trend analysis of Xtant Medical Holdings balance sheet accounts such as Total Assets of 60 M, Other Current Liab of 10 M, Total Current Liabilities of 16 M or Total Stockholder Equity of 53.9 M provides information on Xtant Medical's total assets, liabilities, and equity, which is the actual value of Xtant Medical Holdings to its prevalent stockholders. By breaking down trends over time using Xtant Medical balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Financial Statement Analysis is much more than just reviewing and examining Xtant Medical Holdings latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Xtant Medical Holdings is a good buy for the upcoming year.
Xtant Medical Inventory |
|
Xtant |
About Xtant Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of Xtant Medical Holdings at a specified time, usually calculated after every quarter, six months, or one year. Xtant Medical Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Xtant Medical and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Xtant currently owns. An asset can also be divided into two categories, current and non-current.
Xtant Medical Balance Sheet Chart
Add Fundamental
Total Assets
Total assets refers to the total amount of Xtant Medical assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Xtant Medical Holdings books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Accounts Payable
An accounting item on the balance sheet that represents Xtant Medical obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Xtant Medical Holdings are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.Most accounts from Xtant Medical's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Xtant Medical Holdings current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Xtant Medical Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. At this time, Xtant Medical's Total Liabilities is comparatively stable compared to the past year. Non Current Assets Total is likely to gain to about 28.2 M in 2024, whereas Net Debt is likely to drop slightly above 17 M in 2024.
2021 | 2022 | 2023 | 2024 (projected) | Other Current Liabilities | 3.9M | 5.0M | 9.5M | 10.0M | Total Assets | 54.7M | 60.2M | 92.6M | 60.0M |
Xtant Medical balance sheet Correlations
Click cells to compare fundamentals
Xtant Medical Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Xtant Medical balance sheet Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 43.2M | 41.5M | 54.7M | 60.2M | 92.6M | 60.0M | |
Other Current Liab | 7K | 5.7M | 3.9M | 5.0M | 9.5M | 10.0M | |
Total Current Liabilities | 9.4M | 25.6M | 11.1M | 15.2M | 23.0M | 16.0M | |
Total Stockholder Equity | (44.2M) | 14.5M | 30.9M | 34.2M | 51.3M | 53.9M | |
Net Debt | 73.3M | 16.2M | (1.4M) | (3.2M) | 17.8M | 17.0M | |
Retained Earnings | (223.3M) | (230.3M) | (235.2M) | (243.7M) | (243.0M) | (230.9M) | |
Accounts Payable | 2.2M | 2.3M | 2.6M | 3.5M | 7.1M | 4.9M | |
Cash | 5.2M | 2.3M | 18.2M | 20.3M | 5.7M | 5.8M | |
Cash And Short Term Investments | 5.2M | 2.3M | 18.2M | 20.3M | 5.7M | 5.8M | |
Net Receivables | 10.1M | 6.9M | 7.2M | 10.9M | 20.7M | 21.8M | |
Common Stock Shares Outstanding | 13.2M | 28.5M | 85.5M | 94.1M | 126.8M | 133.1M | |
Liabilities And Stockholders Equity | 43.2M | 41.5M | 54.7M | 60.2M | 92.6M | 60.0M | |
Inventory | 16.1M | 21.4M | 17.9M | 17.3M | 36.9M | 38.7M | |
Other Current Assets | 784K | 1.5M | 988K | 1.6M | 1.5M | 830.2K | |
Other Stockholder Equity | 179.1M | 244.9M | 266.1M | 277.8M | 294.3M | 309.0M | |
Total Liab | 87.4M | 27.0M | 23.8M | 26.1M | 41.3M | 60.8M | |
Total Current Assets | 32.2M | 31.4M | 44.3M | 49.3M | 64.9M | 33.6M | |
Short Long Term Debt Total | 78.5M | 18.5M | 16.8M | 17.1M | 23.6M | 22.4M | |
Property Plant And Equipment Net | 6.8M | 6.0M | 6.5M | 7.2M | 10.2M | 7.8M | |
Non Current Assets Total | 10.9M | 10.1M | 10.4M | 10.9M | 27.7M | 28.2M | |
Non Currrent Assets Other | 394K | 402K | 287K | 197K | 141K | 134.0K | |
Non Current Liabilities Total | 78.0M | 1.3M | 12.7M | 10.8M | 18.3M | 17.4M | |
Property Plant And Equipment Gross | 6.8M | 4.3M | 6.5M | 7.2M | 29.9M | 31.4M | |
Short Term Debt | 570K | 17.7M | 4.6M | 6.8M | 6.4M | 3.9M | |
Intangible Assets | 515K | 457K | 400K | 344K | 10.1M | 7.8M | |
Other Assets | 394K | 2.1M | 287K | 197K | 1.0 | 0.95 | |
Long Term Debt | 77.9M | 76.2M | 11.8M | 9.7M | 17.2M | 16.3M | |
Property Plant Equipment | 6.8M | 4.3M | 6.5M | 5.8M | 6.7M | 7.6M | |
Retained Earnings Total Equity | (215.0M) | (223.3M) | (230.3M) | (243.7M) | (219.3M) | (208.3M) | |
Net Tangible Assets | (47.9M) | 10.9M | 27.3M | 30.6M | 35.2M | 37.0M | |
Long Term Debt Total | 138.6M | 78.1M | 76.2M | 9.7M | 8.7M | 8.3M | |
Capital Surpluse | 171.3M | 179.1M | 244.9M | 277.8M | 319.5M | 177.0M | |
Capital Lease Obligations | 2.3M | 1.7M | 1.4M | 1.7M | 1.8M | 1.6M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Xtant Stock Analysis
When running Xtant Medical's price analysis, check to measure Xtant Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xtant Medical is operating at the current time. Most of Xtant Medical's value examination focuses on studying past and present price action to predict the probability of Xtant Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xtant Medical's price. Additionally, you may evaluate how the addition of Xtant Medical to your portfolios can decrease your overall portfolio volatility.